Cervical Cancer Clinical Trials

Find Cervical Cancer Clinical Trials Near You

Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a prospective, blinded, single-center, randomized controlled trial. Investigators will include 208 patients with postoperative urinary retention (POUR) after radical hysterectomy for cervical cancer who have a clear diagnosis and meet the screening criteria. Participants will be randomly divided into the electroacupuncture(EA)group and the sham EA group according to a 1:1 ratio. Each group consists of 104 patients, and all participants will be required to sign a written informed consent form. The TEAS group will be treated with EA based on conventional treatment, and the shamEA group will be treated with sham EA based on conventional treatment. The main outcomes will be to calculate the proportion of patients who successfully removed the urinary catheter, and the secondary indicators will include the change in post-void residual (PVR) volume of the bladder, assessment of urinary tract infection (UTI), and quality of life assessment according to the EORTC QLQ-C30 scale. Evaluation of participant-reported expectations, blinding, compliance, and safety will also be conducted. All analyses will be conducted in accordance with the intention-to-treat principle.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• ① 18 to 70 years old;

• ② Anticipated survival of at least 6 months;

• ③ Met the diagnostic criteria for POUR of cervical cancer, and the duration of POUR is less than 6 months;

• ④ No serious urinary system disease in the past, and no urinary retention before operation;

• ⑤ Karnofsky functional status score (KPS) ≥ 70 points;

• ⑥ Stable vital signs, no serious mental illness, capable of daily living, able to cooperate in completing all treatments and examinations;

• ⑦ Voluntarily participate and sign a written informed consent form.

Locations
Other Locations
China
Zhejiang Cancer Hospital
RECRUITING
Hangzhou
Contact Information
Primary
Chao Lu
1069103617@qq.com
15869128904
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 208
Treatments
Experimental: The EA Group
Participants will receive the EA intervention for two consecutive weeks.
Sham_comparator: The sham EA Group
Participants will receive the sham EA intervention for two consecutive weeks.
Sponsors
Leads: Lu Chao

This content was sourced from clinicaltrials.gov